213 related articles for article (PubMed ID: 37647825)
1. Indications for the use of intravenous second-line antiseizure medications in an emergency room setting.
Pöytäkangas T; Saarinen JT; Basnyat P; Rainesalo S; Peltola J
Epilepsy Res; 2023 Oct; 196():107218. PubMed ID: 37647825
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy.
Takeuchi H; Higurashi N; Toga Y
Brain Dev; 2024 Jun; 46(6):219-223. PubMed ID: 38519270
[TBL] [Abstract][Full Text] [Related]
3. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
[TBL] [Abstract][Full Text] [Related]
4. Parenteral Long-Acting Antiseizure Medications Are Used More Often to Treat Seizure Clusters Than Convulsive Status Epilepticus in the Pediatric Emergency Department.
Pfeiffer CK; Mackay MT; Long E; Stephens D; Dalziel SR; Babl FE;
J Child Neurol; 2022 Jun; 37(7):589-598. PubMed ID: 35142572
[No Abstract] [Full Text] [Related]
5. Reponse of second-line treatment in focal status epilepticus: A tertiary hospital experience.
Llauradó A; Campos D; Quintana M; Ballvé A; Fonseca E; Abraira L; Giffreu A; Toledo M; Santamarina E
Epilepsy Res; 2022 Sep; 185():106988. PubMed ID: 35907324
[TBL] [Abstract][Full Text] [Related]
6. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two-year prospective surveillance study.
Meyer S; Langer J; Poryo M; Bay JG; Wagenpfeil S; Heinrich B; Nunold H; Strzelczyk A; Ebrahimi-Fakhari D
Epilepsia Open; 2023 Jun; 8(2):411-424. PubMed ID: 36764666
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing nonconvulsive status epilepticus: Defining electroencephalographic and clinical response to diagnostic intravenous antiseizure medication trials.
Leitinger M; Gaspard N; Hirsch LJ; Beniczky S; Kaplan PW; Husari K; Trinka E
Epilepsia; 2023 Sep; 64(9):2351-2360. PubMed ID: 37350392
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus.
Bravo P; Vaddiparti A; Hirsch LJ
Drugs; 2021 May; 81(7):749-770. PubMed ID: 33830480
[TBL] [Abstract][Full Text] [Related]
9. Risk of seizure clusters and status epilepticus following rapid and ultra-rapid medication discontinuation during intracranial EEG monitoring.
Malgireddy K; Gupta N; Baang HY; Samson KK; Madhavan D; Puccioni M; Taraschenko O
Epilepsy Res; 2021 Nov; 177():106756. PubMed ID: 34543831
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
[TBL] [Abstract][Full Text] [Related]
11. Recent antiseizure medications in the Intensive Care Unit.
Orinx C; Legros B; Gaspard N
Minerva Anestesiol; 2017 Aug; 83(8):878-887. PubMed ID: 28492297
[TBL] [Abstract][Full Text] [Related]
12. Non-convulsive status epilepticus in the setting of cannabidiol adjunctive therapy.
Tanwir A; Szabó CÁ
Epileptic Disord; 2022 Aug; 24(4):713-718. PubMed ID: 35770762
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Antiseizure Medications in Wolf-Hirschhorn Syndrome.
Horiguchi A; Koichihara R; Kikuchi K; Nonoyama H; Daida A; Oba D; Hirata Y; Matsuura R; Ohashi H; Hamano SI
Neuropediatrics; 2023 Oct; 54(5):339-343. PubMed ID: 37075791
[TBL] [Abstract][Full Text] [Related]
15. Intravenous brivaracetam for the management of refractory focal non-convulsive status epilepticus.
Ammar AA; Ammar MA; Owusu K; Gilmore EJ
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33229472
[TBL] [Abstract][Full Text] [Related]
16. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
[TBL] [Abstract][Full Text] [Related]
17. Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study.
Rollo E; Romozzi M; Dono F; Bernardo D; Consoli S; Anzellotti F; Ricciardi L; Paci L; Sensi SL; Della Marca G; Servidei S; Calabresi P; Vollono C
Epilepsy Behav; 2023 Mar; 140():109093. PubMed ID: 36739634
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral perampanel in status epilepticus and acute repetitive seizures in children at a tertiary care hospital in Thailand.
Wachiropathum P; Nabangchang C; Likasitthananon N; Suwanpakdee P
Epilepsy Behav; 2021 May; 118():107964. PubMed ID: 33866126
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Treatment of Status Epilepticus.
Lee SK
J Epilepsy Res; 2020 Dec; 10(2):45-54. PubMed ID: 33659195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
